TCL Archive FDA approval of two colon cancer therapies triggers discussion among researchers, clinicians about best treatment and clinical trial designs. CMS reimbursement pending; costs to U.S. of the new drugs could be billions per year, but some predict dramatic increases in survival. March 5, 2004
TCL Archive Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement October 28, 2011
